Liver Transplantation Avoided in Patients With Fulminant Hepatic Failure Who Received Albumin Dialysis With the Molecular Adsorbent Recirculating System While on the Waiting List: Impact of the Duration of Therapy

@article{Camus2009LiverTA,
  title={Liver Transplantation Avoided in Patients With Fulminant Hepatic Failure Who Received Albumin Dialysis With the Molecular Adsorbent Recirculating System While on the Waiting List: Impact of the Duration of Therapy},
  author={Christophe Camus and Sylvain Lavou{\'e} and Arnaud Gacouin and Philippe Compagnon and Karim Boudjema and Christian Jacquelinet and R{\'e}mi Thomas and Yves le Tulzo},
  journal={Therapeutic Apheresis and Dialysis},
  year={2009},
  volume={13}
}
Eighteen patients with fulminant hepatic failure due to various medical causes were listed for emergency liver transplantation and treated with extracorporeal albumin dialysis sessions using the molecular adsorbent recirculating system (MARS) at our center over a 74‐month period. Due to improvement of liver function, transplantation could be avoided in 9 patients (50%, 95% confidence interval 29% to 71%) who fully recovered afterwards. This improvement rate was higher than the rate of… 
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: The RELIEF trial
TLDR
At scheduled doses, a beneficial effect on survival of MARS therapy in patients with ACLF could not be demonstrated, however, MARS has an acceptable safety profile, has significant dialysis effect, and nonsignificantly improves severe HE.
Outcome of patients treated with molecular adsorbent recirculating system albumin dialysis: A national multicenter study
TLDR
It is suggested that MARS should be mainly used as a bridge to liver transplantation, and survival was correlated with being listed for most etiologies and with the intensity of treatment in ALF.
The molecular adsorbent recirculating system in posthepatectomy liver failure: Results from a prospective phase I study
TLDR
The use of MARS in PHLF is feasible and safe and improves liver function in patients with PHLf, and the 60‐ and 90‐day mortality rates were unexpectedly low compared to a historical control group.
Albumin Dialysis With a Noncell Artificial Liver Support Device in Patients With Acute Liver Failure
TLDR
This randomized trial of MARS in patients with ALF was unable to provide definitive efficacy or safety conclusions because many patients had transplantation before administration of the intervention.
Extracorporeal liver support with multipass albumin dialysis or plasmapheresis and filtering systems in acute liver failure
  • A. Bacher
  • Medicine
    Liver international : official journal of the International Association for the Study of the Liver
  • 2011
TLDR
With regional citrate antICOagulation for multipass albumin dialysis and filtering, the need for systemic anticoagulation – a potentially very harmful measure in these patients – can be eliminated and the rate of filter clotting can extremely effectively be reduced.
MARS: Should I Use It?
TLDR
This review aims to discuss the controversies, potential benefits, practicalities, and disadvantages of using MARS in clinical practice.
The molecular adsorbent recirculating system as a liver support system: summary of Mexican experience.
TLDR
The results suggest that MARS therapy can contribute to native liver recovery in ALF patients, and is a safe and effective procedure, especially for ALf patients.
Bridging Therapies and Liver Transplantation in Acute Liver Failure; 10 Years of MARS Experience from Finland
TLDR
Better prognostic markers than hepatic encephalopathy should be used to assess the need for liver transplantation in acute liver failure, especially in patients with a completely necrotic liver.
Is there a role for extracorporeal liver support as a bridge to liver transplantation in acute liver failure?
TLDR
These data demonstrate that although there is a role for prolonging survival to transplantation in ALF, the majority of patients do undergo liver transplantation promptly, and in countries where donor pools are more limited, the proportion of patients with ALF dying before transplantation may be higher.
Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group
TLDR
An evidence-based appraisal of this field is established and a set of consensus recommendations to standardize care and direct further research for patients with cirrhosis and renal dysfunction are developed.
...
1
2
3
4
...

References

SHOWING 1-10 OF 38 REFERENCES
Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation
TLDR
A statistically significant improvement of liver function was observed after MARS therapy, andTransplant-free recovery was more frequent than expected and the apparent benefit of MARS dialysis to treat acute liver failure needs to be confirmed by a controlled study.
Value of albumin dialysis therapy in severe liver insufficiency
TLDR
MARS is a promising therapy for ALF, allowing the patient’s own liver to recover or allowing enough time to find a liver graft, but did not observe much benefit in patients with severe acute-on-chronic liver failure (AcoChr) who did not undergo liver transplantation.
The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients *
TLDR
MARS treatment might partly explain the trend toward increased survival of ALF patients with unknown etiology, and Interpretation of the results was difficult in toxic etiology patients on account of differing baseline statuses.
Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis.
TLDR
MARS resulted in improved liver biochemistry, cardiovascular haemodynamics, renal function and encephalopathy in patients with severe AH, with an apparent reduction in mortality, and a multi-centre, randomized clinical trial is initiated.
Early indicators of prognosis in fulminant hepatic failure.
The successful use of orthotopic liver transplantation in fulminant hepatic failure has created a need for early prognostic indicators to select the patients most likely to benefit at a time when
Characterization of treatment dose delivered by albumin dialysis in the treatment of acute renal failure associated with severe hepatic dysfunction.
TLDR
Albumin dialysis appears capable of improving the outcome in patients with ALCF and hepatorenal syndrome and can deliver an adequate dose of dialysis with respect to urea, according to a similar approach to solute remove.
Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system.
TLDR
Heparin-minimized MARS did not compromise circuit function and longevity in extended intermittent MARS, and priming with heparin saline was safe.
THE EFFECT OF ALBUMIN DIALYSIS ON CYTOKINE LEVELS IN ACUTE LIVER FAILURE AND NEED FOR LIVER TRANSPLANTATION
TLDR
In theory, MARS albumin dialysis may remove toxic substances from the blood circulation and thereby improve the possibilities of the liver to recover; however, of the measured cytokines only IL-10 decreased significantly, which in this setting could be interpreted as a positive effect.
Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson's disease
  • S. Sen, M. Felldin, +5 authors R. Jalan
  • Medicine
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2002
TLDR
Analysis of albumin‐dialysate from the MARS circuit suggested that copper removal occurred mostly in the first few hours of treatment, partly being adsorbed by albumin and partly by the MARSFlux membrane.
A 3‐year experience with Molecular Adsorbent Recirculating System (MARS): our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion
  • G. Novelli, M. Rossi, +6 authors R. Cortesini
  • Medicine
    Liver international : official journal of the International Association for the Study of the Liver
  • 2003
TLDR
A clear correlation between the improvement in clinical conditions (especially neurological status) and improvement in cerebral perfusion, measured by color Doppler US is demonstrated.
...
1
2
3
4
...